King D J
U.S. Department of Agriculture, Southeast Poultry Research Laboratory, Athens, Georgia 30605.
Avian Dis. 1988 Apr-Jun;32(2):335-41.
Replicate hemagglutination-inhibition (HI) tests of selected convalescent and hyperimmune infectious bronchitis virus (IBV) antisera were run against five IBV antigens: Massachusetts 41, Connecticut 46, H52, Arkansas 99, and JMK. Six different HI test procedures were included in this comparison to evaluate the effect of procedural differences on HI titers. The results were similar among procedures to the extent that positive and negative reactions were differentiated by each procedure with each antigen. This indicated that specificity was not affected by the procedure. However, the mean titers did differ among procedures in tests of the same serum-antigen combination, and the range of the titer differences was frequently fourfold or greater. Generally, high or low titers were associated with specific procedures, regardless of which test antigen was used.
针对五种传染性支气管炎病毒(IBV)抗原:马萨诸塞州41株、康涅狄格州46株、H52株、阿肯色州99株和JMK株,对选定的恢复期和超免疫传染性支气管炎病毒(IBV)抗血清进行了重复血凝抑制(HI)试验。本次比较纳入了六种不同的HI试验程序,以评估程序差异对HI效价的影响。各程序之间的结果相似,每种程序对每种抗原都能区分阳性和阴性反应。这表明特异性不受程序影响。然而,在相同血清-抗原组合的试验中,各程序的平均效价确实存在差异,效价差异范围经常达到四倍或更大。一般来说,无论使用哪种试验抗原,高或低效价都与特定程序相关。